Skip to Main Content

Author Details

Wei Zhu
Georgia Cancer Center, Medical College of Georgia
2008
30
22
PMIDPaper TitleJournal TitlePublished Year
32395117Preclinical Studies of the Off-Target Reactivity of AFP<sub>158</sub>-Specific TCR Engineered T Cells.Front Immunol2020
32425926Selection of a Clinical Lead TCR Targeting Alpha-Fetoprotein-Positive Liver Cancer Based on a Balance of Risk and Benefit.Front Immunol2020
30778251The transcription factor c-Myb regulates CD8<sup>+</sup> T cell stemness and antitumor immunity.Nat Immunol2019
31299995Genomic landscape and its correlations with tumor mutational burden, PD-L1 expression, and immune cells infiltration in Chinese lung squamous cell carcinoma.J Hematol Oncol2019
29075958A rare case of B-lymphoproliferative disorder with villous lymphocytes harboring t(8;14)(q24;q32) translocation.Front Med2018
28802071MicroRNA-137 and microRNA-195* inhibit vasculogenesis in brain arteriovenous malformations.Ann Neurol2017
29242501High-throughput RNA sequencing reveals distinct gene signatures in active IgG4-related disease.Sci Rep2017
27093186Genomic Landscape Survey Identifies SRSF1 as a Key Oncodriver in Small Cell Lung Cancer.PLoS Genet2016
26578606BubbleTree: an intuitive visualization to elucidate tumoral aneuploidy and clonality using next generation sequencing data.Nucleic Acids Res2016
26663909Identification of Cyclin-Dependent Kinase 1 as a Novel Regulator of Type I Interferon Signaling in Systemic Lupus Erythematosus.Arthritis Rheumatol2016
27481557Identification of the long noncoding RNA NEAT1 as a novel inflammatory regulator acting through MAPK pathway in human lupus.J Autoimmun2016
25963922MiR-125a targets effector programs to stabilize Treg-mediated immune homeostasis.Nat Commun2015
26653219HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinoma.J Transl Med2015
26587322A high density of tertiary lymphoid structure B cells in lung tumors is associated with increased CD4<sup>+</sup> T cell receptor repertoire clonality.Oncoimmunology2015
23434567A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients.Ann Rheum Dis2014
24757153Inhibition of myogenic microRNAs 1, 133, and 206 by inflammatory cytokines links inflammation and muscle degeneration in adult inflammatory myopathies.Arthritis Rheumatol2014
24571613Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lower epithelial-mesenchymal transition signature and longer survival in squamous cell lung carcinoma.BMC Cancer2014
24289491MicroRNA-206 induces G1 arrest in melanoma by inhibition of CDK4 and Cyclin D.Pigment Cell Melanoma Res2014
24357810Suppression of soluble T cell-associated proteins by an anti-interferon-α monoclonal antibody in adult patients with dermatomyositis or polymyositis.Rheumatology (Oxford)2014
24118906The evaluation of efficacy and safety of sunitinib on EGFR-TKI pretreated advanced non-small cell lung cancer patients in China.Clin Respir J2014
24200637Low frequency KRAS mutations in colorectal cancer patients and the presence of multiple mutations in oncogenic drivers in non-small cell lung cancer patients.Cancer Genet2013
21881594Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis.Genes Immun2012
23171592Genomic signatures characterize leukocyte infiltration in myositis muscles.BMC Med Genomics2012
22235269Interferon and biologic signatures in dermatomyositis skin: specificity and heterogeneity across diseases.PLoS One2012
22324944Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients.Int J Rheum Dis2012
21860416A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth.Oncogene2012
21803750Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway.Ann Rheum Dis2011
22046260Altered expression of insulin receptor isoforms in breast cancer.PLoS One2011
20153794A whole genome transcriptional analysis of the early immune response induced by live attenuated and inactivated influenza vaccines in young children.Vaccine2010
18554403Analysis of 90 Mb of the potato genome reveals conservation of gene structures and order with tomato but divergence in repetitive sequence composition.BMC Genomics2008
  • 1 - 30 of 30

Recommended Authors

University of Texas Southwestern Medical Center
Career Start Year 2014
Number of shared co-authors 0
Massachusetts Institute of Technology
Career Start Year 2013
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2010
Number of shared co-authors 0
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2010
Number of shared co-authors 3
the University of Texas MD Anderson Cancer Center
Career Start Year 2009
Number of shared co-authors 0
University of California los angeles
Career Start Year 2008
Number of shared co-authors 0
UPMC Hillman Cancer Center
Career Start Year 2007
Number of shared co-authors 0
St Vincent's Hospital Melbourne
Career Start Year 2006
Number of shared co-authors 0
The University of Texas M. D. Anderson
Career Start Year 2006
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2005
Number of shared co-authors 2
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 0
Present address: Dxige Research Inc.
Career Start Year 2003
Number of shared co-authors 0
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Medical University of Vienna
Career Start Year 2001
Number of shared co-authors 0
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 0
Bloomberg-Kimmel Immunotherapy Institute, Johns Hopkins University School of Medicine
Career Start Year 2001
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 0
Stanford Center for Biomedical Informatics Research, Stanford University
Career Start Year 1999
Number of shared co-authors 0
Merck & Co., Inc.
Career Start Year 1998
Number of shared co-authors 0
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 0
The Ohio State University
Career Start Year 1997
Number of shared co-authors 0
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 0
Caryl and Israel Englander Institute for Precision Medicine.
Career Start Year 1993
Number of shared co-authors 0
Center for Cellular Engineering, National Institutes of Health Clinical Center
Career Start Year 1993
Number of shared co-authors 4
Cedars-Sinai Medical Center
Career Start Year 1992
Number of shared co-authors 0
Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield
Career Start Year 1991
Number of shared co-authors 0
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 0
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Career Start Year 1974
Number of shared co-authors 5

Collaborators

Cellular Biomedicine Group Inc.
Co-authored papers 25
Translational and Clinical Data Sciences
Co-authored papers 20
Oncology R&D Unit
Co-authored papers 15
MedImmune LLC
Co-authored papers 13
MedImmune LLC
Co-authored papers 13
Massachusetts General Hospital
Co-authored papers 6
Brigham Women's Hospital, Harvard Medical School
Co-authored papers 4
Corbus Pharmaceuticals Holdings
Co-authored papers 2
BioKien LLC
Co-authored papers 2
Parker Institute for Cancer Immunotherapy
Co-authored papers 1
Oncology R&D
Co-authored papers 1
National Cancer Institute, National Institutes of Health (NIH)
Co-authored papers 1
University of Cincinnati College of Medicine
Co-authored papers 1
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
National Cancer Institute, National Institutes of Health
Co-authored papers 1
VA Boston Healthcare System
Co-authored papers 1
US Department of Veterans Affairs Medical Center
Co-authored papers 1
Present Address: Tempus Labs Inc.
Co-authored papers 1
Co-authored papers 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Abigail Wexner Research Institute, Nationwide Children's Hospital
Co-authored papers 1
Boston Children's Hospital, Seoul National University, Seoul National University Hospital
Co-authored papers 1